KRISTI STEWART: Open Payments
NPI 1407341902 · ALBANY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$995 in 60 payments from 11 companies in 2025. Trend: 2023 $822 · 2024 $2,003 · 2025 $995
Food & beverage: $995
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $490 |
| Janssen Biotech, Inc. | 5 | $102 |
| Aimmune Therapeutics, Inc. | 4 | $83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 6 | $59 |
| Madrigal Pharmaceuticals | 2 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $43 |
| Lilly USA, LLC | 2 | $43 |
| GENZYME CORPORATION | 1 | $22 |
| IRONWOOD PHARMACEUTICALS, INC | 1 | $21 |
Products named: RINVOQ, CREON, TREMFYA, ZENPEP, MAVYRET, LINZESS, XIFAXAN, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
